arcadia

SUVEN LIFE SCIENCES LTD.

NSE : SUVENBSE : 530239ISIN CODE : INE495B01038Industry : Pharmaceuticals & DrugsHouse : Private
BSE256.002.6 (+1.03 %)
PREV CLOSE ( ) 253.40
OPEN PRICE ( ) 250.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 28365
TODAY'S LOW / HIGH ( )245.40 257.40
52 WK LOW / HIGH ( )183.25 337.7
NSE256.453.25 (+1.28 %)
PREV CLOSE( ) 253.20
OPEN PRICE ( ) 253.00
BID PRICE (QTY) 256.45 (1899)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 139530
TODAY'S LOW / HIGH( ) 245.00 257.70
52 WK LOW / HIGH ( )182.7 337.8
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 09-03 1989
Management Info
Venkateswarlu Jasti - Chairman - Managing Director
Registered Office

Address 8-2-334, S D E Serene Chambers,6th Floor, Road No 5, Avenue 7,Banjara Hills,
Hyderabad,
Telangana-500034

Phone +91-40- 23541142 23543311 32921695 32921696

Email info@suven.com

Website www.suven.com

Registrars Details
Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
16Aug Disclosure of Voting results of AGM (
Suven Life Sciences Ltd has informed BSE regarding the details of Voting..
14Aug Shareholder Meeting / Postal Ballot-O
This is with reference to our earlier letter dated 20th July, 2019 regar..
26Jul Announcement under Regulation 30 (LOD
Newspaper advertisement regarding reminder to claim the dividends remain..
26Jul Suven Life Sciences informs about news
Suven Life Sciences has informed that the newspaper advertisement regard..
22Jul Notice Of The 30Th Annual General Mee
With reference to the above subject, pursuant to Regulation 34 of the SE..
Financials
Rs. in Millions
QTR Jun 19 ANNUAL 19
Net Profit571.781500.63
Gross Profit 861.82 2218.63
Operating Profit 930.42477.67
Net Sales 1989.866635.04
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi India (BSE)
 6032.65 (1.46%)
M.Cap ( in Cr)13893.57
Astrazeneca Pharma I (BSE)
 1746.40 (4.12%)
M.Cap ( in Cr)4366.00
Piramal Enterprises (BSE)
 1781.40 (3.23%)
M.Cap ( in Cr)35422.53
Abbott India (BSE)
 8786.90 (0.61%)
M.Cap ( in Cr)18671.55
Alkem Laboratories (BSE)
 1771.30 (1.21%)
M.Cap ( in Cr)21178.55
Shareholding Pattern
PROMOTERS 60%
NON-INSTITUTION 32.19%
MUTUAL FUNDS/UTI 1.92%
FI/BANKS/INSURANCE 0.32%
GOVERNMENT 0%
FII 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM